A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Opinion Adopted |
---|---|
Submitter | Netherlands |
Regulatory programme |
|
Further substance information | m-bis(2,3-epoxypropoxy)benzene resorcinol diglycidyl ether; DGRE |
CLP Annex VI Index Number |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Hazard classes open for commenting | Acute toxicity Carcinogenicity |
Intention timeline
Date of intention | 2017-07-31 |
---|---|
Expected date of submission | 2018-02-01 |
Submitted for accordance check | 2017-10-18 |
Final submission date | 2018-02-26 |
Start of consultation | 2018-03-12 |
Deadline for commenting | 2018-05-11 |
Date of opinion | 2018-11-30 |
Legal deadline for opinion adoption | 2019-08-28 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
RAC opinion |
|
Background document |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
April 4, 2019
- Regulatory programme: Other substance → Chemical registered under REACH
March 16, 2020
- Submitter email: bureau-reach@rivm.nl
March 27, 2021
- Name: m-bis(2,3-epoxypropoxy)benzene → m</I>-bis(2,3-epoxypropoxy)benzene; resorcinol diglycidyl ether
April 9, 2021
- Name: m</I>-bis(2,3-epoxypropoxy)benzene; resorcinol diglycidyl ether → m-bis(2,3-epoxypropoxy)benzene
Dec. 10, 2021
- ATP number and date: ATP15 - (19/05/2020), 01/03/2022
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1598259094155&uri=CELEX:32020R1182
This version
Feb. 6, 2019
- Background document: https://echa.europa.eu/documents/10162/63975dff-0bb0-6ebf-8846-325f6f8569ff
- Comments received: https://echa.europa.eu/documents/10162/38c254e8-d65d-ab14-99fb-7fd5f2bb16d6 → https://echa.europa.eu/documents/10162/8c3c84c9-ec8a-5209-de6c-b371e1fa5ef9
- RAC opinion: https://echa.europa.eu/documents/10162/fb5365df-9156-4666-3512-a459ad5bf39b
- Submitter email: bureau-reach@rivm.nl
Dec. 11, 2018
- Date of opinion: 2018-11-30
- Status: Opinion Development → Opinion Adopted
Add the related substance to your watchlist to monitor this regulatory record.